Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Laura Izquierdo‐Sánchez, Ángela Lamarca, Adelaida La Casta, et al.
Journal of Hepatology (2022) Vol. 76, Iss. 5, pp. 1109-1121
Open Access | Times Cited: 214

Showing 26-50 of 214 citing articles:

Unveiling the prognostic role of blood inflammatory indexes in a retrospective cohort of patients undergoing liver resection for intrahepatic cholangiocarcinoma
Flavio Milana, Michela Anna Polidoro, Cristiana Soldani, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7088-7096
Open Access | Times Cited: 5
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma
Cecilia Monge, Changqing Xie, Yuta Myojin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 4
Application of AI on cholangiocarcinoma
Jianhao Huang, Xuesong Bai, Yan-Yu Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Preoperative predictors for non-resectability in perihilar cholangiocarcinoma
Carlos Constantin Otto, Anna Mantas, Lara R. Heij, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation
Ji-Qiao Zhu, Ying Zhu, Man Qi, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 4
Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma
Clémentine Alitti, Agnès Rode, H. Trillaud, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1363-1372
Closed Access | Times Cited: 4
Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real‐world study
Alessandro Ottaiano, Mariachiara Santorsola, Anna Diana, et al.
Cancer Medicine (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 4
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study
Francisco Nolasco, Gilton Marques Fonseca, Evandro Sobroza de Mello, et al.
Journal of Surgical Oncology (2024)
Closed Access | Times Cited: 4
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in Cholangiocarcinoma
Giulia Tesini, Chiara Braconi, Lorenza Rimassa, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 156-156
Open Access
LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma
Ling‐Yu Tang, Yuting Wang, Yongzhen Chen, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Construction and validation of a diagnostic model for cholangiocarcinoma based on tumor-educated platelet RNA expression profiles
Haiyang Hu, Jiefeng He, Haoliang Zhao
ONCOLOGIE (2025)
Closed Access
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Bile-Derived cfDNA of Syncytin-1 and SLC7A11 as a Potential Molecular Marker for Early Diagnosis of Cholangiocarcinoma
Jing He, Jingrong Qian, Xin Li, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Cirugía del colangiocarcinoma intrahepático y perihiliar
A. Facque, Nicolas Golse
EMC - Técnicas Quirúrgicas - Aparato Digestivo (2025) Vol. 41, Iss. 1, pp. 1-20
Closed Access
Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinoma
Younghoon Kim, Jaewon Song, Namkyoung Kim, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
Zhuo Cheng, Xuanmei Luo, Wenzheng Liu, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Research trends and hotspots evolution of artificial intelligence for cholangiocarcinoma over the past 10 years: a bibliometric analysis
Keheng Wang, Yuting Li, Song Yang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe
Anthony Turpin, Tian V. Tian, Alice Boilève, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101215-101215
Open Access
Cholangiocarcinoma as a Biologically Complex and Clinically Challenging Orphan Cancer
Alphonse E. Sirica
American Journal Of Pathology (2025) Vol. 195, Iss. 3, pp. 341-344
Closed Access
Chirurgia del colangiocarcinoma intraepatico e perilare
A. Facque, Nicolas Golse
EMC - Tecniche Chirurgiche Addominale (2025) Vol. 31, Iss. 1, pp. 1-18
Closed Access
Intrahepatic cholangiocarcinoma trends and treatment lines: real-world evidence from the French National Hospital Discharge database
Matthieu Delaye, B. Grenier, Astrid Lièvre, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 8, pp. 100152-100152
Closed Access
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
Yue Liu, Wenrong Jiang, Xiangxiao Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 513-526
Open Access
ASO Author Reflections: Long-Term Outcomes According to Surgical Margin in Mass-forming Cholangiocarcinoma—The Role of R1vasc
Guido Torzilli, Flavio Milana, Fabio Procopio
Annals of Surgical Oncology (2025)
Closed Access

Scroll to top